Date: 13-Aug-2020

Lupin Launches US FDA Approved Generic Zyflo CR Tablets

Pharma major Lupin Limited announces the launch of the United States Food and Drug Administration (FDA) approved Zileuton extended-release tablets, 600 mg.

According to a company press release, the product would be manufactured at Lupin’s Nagpur facility in India.

Zileuton extended-release tablets, 600 mg, is the generic equivalent of Zyflo CR extended-release tablets, 600 mg, of Chiesi USA, Inc. and is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.

Zileuton extended-release tablets had an annual sales of approximately US$ 40 million in the US, according to IQVIA MAT June 2020.